Close

Senseonics Holdings (SENS) Misses Q2 EPS by 2c

Go back to Senseonics Holdings (SENS) Misses Q2 EPS by 2c

Senseonics Holdings, Inc. Reports Second Quarter 2016 Financial Results

August 9, 2016 4:08 PM EDT

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE-MKT: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the second quarter and six months ended June 30, 2016.

RECENT HIGHLIGHTS & ACCOMPLISHMENTS:

Completed the multi-center PRECISE II pivotal clinical investigation in the United States and released topline results. Secured an expanded debt facility with a total potential borrowing limit of up to $30 million with Oxford Finance and Silicon Valley Bank... More